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We have also applied these proteomic methods to studying
protein modiﬁcation in acute hypoxia. In endothelial cells, there is
an increase in cysteine oxidation in several proteins that can
mediate acute responses to hypoxia prior to the activation of the
HIF pathway, and we are currently studying in more detail the role
of protein S-nitrosylation.
We have also recently shown that acute hypoxia produces a
superoxide burst in cells, which can be converted in an oxidative
signal through protein cysteine modiﬁcation, and we are unravel-
ing the molecular mechanisms producing this superoxide burst in
mitochondria.
http://dx.doi.org/10.1016/j.redox.2015.09.027
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Background: Tumor associated macrophages (TAMs) are known to
support tumor progression and their accumulation is generally
associated with poor prognosis. The shift from a tumor-attacking
to a tumor-supportive macrophage phenotype is based on an
educational program that, at least in part, is initiated by apoptotic
tumor cells.
Aims: We explored the macrophage phenotype shift during tumor
progression by analyzing the macrophage NO-output system and
examining potential NO targets.
Methods: Biochemical and Molecular Biology-orientated cell cul-
ture experiments, in part using 3D-tumor spheroid models as well
as animal experiments were used.
Results: Apoptotic cells polarize macrophages towards a healing,
tumor-supportive phenotype. Soluble mediators released from
apoptotic cells, among them the lipid sphingosine-1-phosphate
(S1P), cause expression of arginase 2 in macrophages, thereby
lowering citrulline/NO formation but enhancing ornithine produc-
tion. Mechanistically, this is achieved via the S1P2 receptor and
the CRE (cAMP-response element) binding site in the arginase
2 promoter. Reduced NO-formation is also seen in ex vivo macro-
phages from a xenograft model allowing restricted vs. unrestricted
tumor growth based on tumor-associated S1P-formation. The
theoretical ability of NO to target hypoxia-inducible factor-1
(HIF-1) and jumonji histone demethylases (JHDMs) in cells of
the tumor microenvironment will be discussed in light of the
iNOS/arginase balance. Moreover, data on the importance of HIF-1
in macrophages for their interaction with tumor cells, polarization,
and angiogenic potential will be presented.
Conclusions: We hypothesize that apoptotic death of tumor cells
and associated macrophage activation facilitates the progression of
malignant disease. The macrophage polarization program affects
the NO-output system and the capacity of macrophages to support
or restrict tumor growth.
http://dx.doi.org/10.1016/j.redox.2015.09.028
Young Investigation Session
Selected Oral Communications
Polymorphisms In The Nitric-Oxide Synthase 2 Gene
And Prostate Cancer Pathogenesis
Charlotta Ryk, Petra de Verdier, Emmie Montgomery, N. Peter
Wiklund, Fredrik Wiklund, Henrik Grönberg
Department of Molecular Medicine and Surgery, Karolinska Institutet,
Stockholm, Sweden
Background: Nitric-oxide synthase (NOS)-polymorphisms inﬂu-
ence the cellular amount of NO, and are associated with disease-
risk in many disorders. We investigated 145 SNP-polymorphisms
and a (CCTTT)n-microsatellite in the NOS2-gene in 3161 prostate-
cancer patients and 2149 controls from a Swedish population-
based GWAS-study.
Aim: To analyze possible associations between NOS2-polymorph-
isms, prostate cancer, and prostate cancer pathogenesis.
Methods: Two groups were analyzed, those with advanced
tumours (Gleason≥6), and those with tumours of mixed Glea-
son-statues. Affymetrix 5.0-chip (SNP-polymorphisms), DNA Frag-
ment-analysis and Sequencing ((CCTTT)n-microsatellite) were
used for genotyping. Genotypes were combined with information
on tumour stage, Gleason, PSA, metastases and cancer-speciﬁc
death, using clinical follow-up.
Results: We divided the (CCTTT)n-alleles into short (S, n≤10),
intermediate (M, n¼11-12) and long (L, n≥13). Patients homo-
zygous for longer repeats (LL) had decreased risk of highly
aggressive (Gleason ≥7;PSA420;T3+) tumours (OR:0.40;CI:0.14-
1.08;p¼0.071), but, once ill they showed a threefold increased risk
of dying in prostate cancer (HR:3.31;CI:0.85-12.85;p¼0.084),
compared to SS-homozygotes. The SNP-alleles that co-varied with
the (CCTTT)L-allele also had lower risk of aggressive tumours, as
well as, once ill, a 2-4 times higher risk of dying (p¼0.009). Also
the proportion of patients with lymph node metastases increased
with length of the (CCTTT)n-alleles of the patients (SSoSMo-
SLoMMoML oLL)(trend analysis; p¼0.033).
Conclusions: Nitric oxide can induce proliferation as well as
apoptosis depending on cellular context. Our results suggest that
NOS2 polymorphisms may inﬂuence the risk of aggressive prostate
cancer and that these polymorphisms could have an impact on
disease pathogenesis, possibly by affecting intracellular nitric
oxide levels.
http://dx.doi.org/10.1016/j.redox.2015.09.029
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